AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,580.00
-10.00 (-0.13%)
Jun 27, 2025, 3:30 PM KST

AptaBio Therapeutics Revenue

AptaBio Therapeutics had revenue of 382.70M KRW in the quarter ending March 31, 2025, a decrease of -39.94%. This brings the company's revenue in the last twelve months to 3.11B, up 229.91% year-over-year. In the year 2024, AptaBio Therapeutics had annual revenue of 3.36B with 937.76% growth.

Revenue (ttm)
3.11B
Revenue Growth
+229.91%
P/S Ratio
65.59
Revenue / Employee
n/a
Employees
n/a
Market Cap
203.76B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243.36B3.04B937.76%
Dec 31, 2023323.87M275.52M569.80%
Dec 31, 202248.35M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition